Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Ida Sonni"'
Autor:
John Nikitas, Andrei Gafita, Matthias R. Benz, Loïc Djaïleb, Andrea Farolfi, Masatoshi Hotta, Ida Sonni, Rejah Alano, Matthew Rettig, John Shen, Wesley Armstrong, Tristan Grogan, Sandy Liu, Johannes Czernin, Jeremie Calais
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract For prostate cancer patients who experience biochemical progression during androgen deprivation therapy (ADT), prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has not been prospectively compa
Externí odkaz:
https://doaj.org/article/2d25a6d37a594d7b82be5f6b5ab994d5
Autor:
Ida Sonni, Andrei Gafita, Lena M. Unterrainer, Rejah M. Alano, Stephanie Lira, John Shen, Alexandra Drakaki, Tristan Grogan, Matthew B. Rettig, Johannes Czernin, Jeremie Calais
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Background PSMA expression is influenced by hormonal status. We evaluated changes in PSA and whole-body 68Ga-PSMA-11 PET/CT (WB-PSMA PET) after initiation of androgen receptor signaling inhibitors (ARSi). Methods Prospectively enrolled patie
Externí odkaz:
https://doaj.org/article/fc9be906f81d4f2fb2a2b86d91fd4eaf
Autor:
Vishnu Murthy, Emmanuel Appiah-Kubi, Kathleen Nguyen, Pan Thin, Masatoshi Hotta, John Shen, Alexandra Drakaki, Matthew Rettig, Andrei Gafita, Jeremie Calais, Ida Sonni
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Purpose To evaluate whether quantitative whole-body (WB) PSMA-PET metrics under long-term androgen deprivation therapy (ADT) and/or androgen receptor signaling inhibitors (ARSi) are associated with PSA progression. Methods Patients who under
Externí odkaz:
https://doaj.org/article/50a32eb3847a4d65845ef2925ba1835b
Autor:
Ida Sonni, Orit H. Lesman Segev, Suzanne L. Baker, Leonardo Iaccarino, Deniz Korman, Gil D. Rabinovici, William J. Jagust, Susan M. Landau, Renaud La Joie, for the Alzheimer's Disease Neuroimaging Initiative
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Positron emission tomography targeting tau (tau‐PET) is a promising diagnostic tool for the identification of Alzheimer's disease (AD). Currently available data rely on quantitative measures, and a visual interpretation method
Externí odkaz:
https://doaj.org/article/c7f218404cb64730a9c4c0082d85af83
Autor:
Ida Sonni, Lucia Baratto, Sonya Park, Negin Hatami, Shyam Srinivas, Guido Davidzon, Sanjiv Sam Gambhir, Andrei Iagaru
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-12 (2018)
Abstract Background A newly introduced PET/CT scanner (Discovery Meaningful Insights—DMI, GE Healthcare) includes the silicon photomultiplier (SiPM) with time-of-flight (TOF) technology first used in the GE SIGNA PET/MRI. In this study, we investig
Externí odkaz:
https://doaj.org/article/335a43cf0c5b4f04b880547553d7b8b3
Autor:
Mirwais Wardak, Ida Sonni, Audrey P. Fan, Ryogo Minamimoto, Mehran Jamali, Negin Hatami, Greg Zaharchuk, Nancy Fischbein, Seema Nagpal, Gordon Li, Norman Koglin, Mathias Berndt, Santiago Bullich, Andrew W. Stephens, Ludger M. Dinkelborg, Ty Abel, H. Charles Manning, Jarrett Rosenberg, Frederick T. Chin, Sanjiv Sam Gambhir, Erik S. Mittra
Publikováno v:
Radiology, vol 303, iss 3
Radiology
Radiology
BACKGROUND: The PET tracer (4S)-4-(3-[(18)F]fluoropropyl)-l-glutamate ((18)F-FSPG) targets the system x(C)(–) cotransporter, which is overexpressed in various tumors. PURPOSE: To assess the role of (18)F-FSPG PET/CT in intracranial malignancies. MA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479d61e23cb7b4b588b15e67c41ceb39
https://doi.org/10.1148/radiol.203296
https://doi.org/10.1148/radiol.203296
Autor:
Orit H Lesman-Segev, Renaud La Joie, Melanie L Stephens, Ida Sonni, Richard Tsai, Viktoriya Bourakova, Adrienne V Visani, Lauren Edwards, James P O'Neil, Suzanne L Baker, Raquel C Gardner, MD, Mustafa Janabi, Kiran Chaudhary, David C Perry, Joel H Kramer, Bruce L Miller, William J Jagust, Gil D Rabinovici
Publikováno v:
NeuroImage: Clinical, Vol 24, Iss , Pp - (2019)
Objective: To characterize individual and group-level neuroimaging findings in patients at risk for Chronic Traumatic Encephalopathy (CTE). Methods: Eleven male patients meeting criteria for Traumatic Encephalopathy Syndrome (TES, median age: 64) und
Externí odkaz:
https://doaj.org/article/104d8e061036467790c610c87f2962e4
Autor:
Michael L. Steinberg, Kathleen Nguyen, Vinayak Muralidhar, Neil R. Parikh, Vincent Lok, Ting Martin Ma, Ida Sonni, Andrei Gafita, Pan Thin, David Elashoff, Johannes Czernin, Ricky Savjani, Matthew Rettig, Jesus E. Juarez, Jie Deng, Tristan Grogan, David Shabsovich, Amar U. Kishan, Patrick A. Kupelian, David D. Yang, Jeremie Calais, Nicholas G. Nickols, Carissa Chu, Felix Y. Feng, Wesley R Armstrong, Robert E. Reiter
Publikováno v:
Eur Urol Oncol
European urology oncology, vol 5, iss 1
European urology oncology, vol 5, iss 1
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is an emerging imaging modality with greater sensitivity and specificity over conventional imaging for prostate cancer (PCa) staging. Using data fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2641c06c641ca2b0573c6a4e1e6db325
https://doi.org/10.1016/j.euo.2021.01.006
https://doi.org/10.1016/j.euo.2021.01.006
Autor:
Fatemeh Zabihollahy, Qi Miao, Ida Sonni, Sitaram Vangala, Harrison Kim, William Hsu, Anthony Sisk, Robert Reiter, Steven Raman, Kyunghyun Sung
The risk of prostate cancer (PCa) is strongly influenced by race and ethnicity. The purpose of this study is to investigate differences in the diagnostic performance of multiparametric MRI (mpMRI) in African American (AA) and white (W) men. 111 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a658954cacd861d93952da7888ade8c
https://doi.org/10.21203/rs.3.rs-2547854/v1
https://doi.org/10.21203/rs.3.rs-2547854/v1
Autor:
Staven S Raman, Ida Sonni, Ely Felker, Anthony Sisk, Wesley R Armstrong, Tristan Grogan, Jeremie Calais, Teeravut Tubtawee, Robert E. Reiter, Andrew T. Lenis, David Elashoff, Shadfar Bahri, Johannes Czernin, Matthias Eiber, Martin Allen-Auerbach, Voraparee Suvannarerg
Publikováno v:
Journal of Nuclear Medicine. 63:847-854
The role of prostate-specific membrane antigen (PSMA)-targeted PET in comparison to mpMRI in the evaluation of intraprostatic cancer foci is not well defined. The aim of our study was to compare the diagnostic performances of PSMA PET/CT, mpMRI and P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a334e38294e8b6b5212e57516cf43bd
https://doi.org/10.2967/jnumed.121.262398
https://doi.org/10.2967/jnumed.121.262398